Specialty Pharma: Eating Big Pharma's Lunch, Not Just its Leftovers?
Executive Summary
While not yet rivals to Big Pharma when it comes to clinical-stage licensing, spec pharmas have in some individual cases proven to be more favored partners than their Big Pharma competitors.